Abramson Cancer Center and Basser Center for BRCA, University of Pennsylvania, Philadelphia

Katherine (Kate) L. Nathanson, MD is a Professor of Medicine, in the Division of Translational Medicine and Human Genetics at the Perelman School of Medicine of the University of Pennsylvania. She is Associate Director for Population Sciences in the Abramson Cancer Center, as well as co-Leader of the Cancer Control Program and Chief Oncogenomics Physician, as well as Director of Genetics for the Basser Center for BRCA Research. Dr. Nathanson received her BA from Haverford College and MD from the University of Pennsylvania School of Medicine. She completed residencies in both Internal Medicine and Clinical Genetics, along with a post-doctoral fellowship in cancer genetics.  She is an internationally recognized cancer geneticist/genomicist for both her clinical and research expertise.  Her research focuses on both inherited susceptibility to cancer and somatic genetic characterization of tumors, with interests across multiple tumor types, including testicular germ cell tumors, hereditary breast and ovarian cancers, melanoma and neuroendocrine tumors. Dr. Nathanson has published over 250 peer-reviewed articles in journals such as Nature, JAMA, New England Journal of Medicine and Cancer Cell. Dr. Nathanson has an extensive record of national service, serving on committees for multiple organizations, such as ACMG and AACR, several editorial boards, and scientific review committees including as Chair of the Cancer Genetics study section for the National Institutes of Health. She has been elected to the American Society of Clinical Investigation and the American Association of Physicians.